StaniPharm
PrivateLast Round
Seed
Jun 15, 2010
Total Funding Raised
$490,000
Company Overview
StaniPharm operates in Healthcare & Life Sciences and is based in Champigneulles. Its latest recorded funding round was a Seed round in June 2010.
StaniPharm is a life sciences company that operates as a Contract Development and Manufacturing Organization (CDMO) providing development and GMP manufacturing services with a focus on supercritical CO2 technologies and nanomedicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StaniPharm Comparables
Compare StaniPharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crystec Pharma | 85% | |
| CritiTech | 84% | |
| Nanoform Finland Oyj | 81% |
For institutional investors. Book with your work email.
StaniPharm Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
StaniPharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institut Lorrain de Participation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Monthly visitors increased 279% MoM.
- Oct 26, 2024
Monthly visitors increased 177% MoM.
For institutional investors. Book with your work email.
StaniPharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StaniPharm's valuation, stock price, and market status.
Is StaniPharm a public or private company?
StaniPharm is a private company.
What is the current stock price of StaniPharm?
StaniPharm is a private company, so its shares have no public market price. Caplight tracks StaniPharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StaniPharm worth (valuation)?
Valuation information for StaniPharm is not publicly available.
Can I buy StaniPharm stock?
StaniPharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StaniPharm's last funding round?
StaniPharm's most recent funding round was Seed on June 15, 2010.
Who are the main investors in StaniPharm?
Key investors in StaniPharm include Institut Lorrain de Participation.
Will StaniPharm IPO soon?
No public IPO plans have been announced for StaniPharm.
How can I track StaniPharm secondary market activity?
Caplight tracks bids, offers, and trades in StaniPharm's shares on secondary markets.